Key facts
- Ansana’s last known valuation is $6.2M (Sep 2025).
- It has raised $3.0M; the latest was Early Stage VC in Jan 2027.
- Notable investors include NLC Health Ventures, Healthliant Ventures, Peachscore + Gust Accelerator Program, ScaleNL, Sitem Startup Club.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Ansana
- ·The full record, as it builds
Funding rounds
No funding rounds for Ansana are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ansana
Developer of an innovative surgical instrument reprocessing technology designed to enhance patient safety, sustainability, and efficiency in healthcare. The company offers a smart medical device, integrated data modules, and industrial process expertise, enabling healthcare providers to improve service delivery and ensure higher standards in surgical instrument management.
- Sector
- Healthcare
- HQ
- Maastricht, Netherlands
- Founded
- 2022
- Employees
- 10
- Website
- ansana.health/
- Ownership
- Privately Held (backing)
Ansana doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ansana shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ansana in its N-PORT filings yet. We sweep new filings monthly.